Influence of thrombolytic therapy on the patterns of ventricular septal rupture after acute myocardial infarction

Postgraduate Medical Journal

Volumn 78, Issue 921, 2002, Pages 408-412

  Rhydwen, G R ^a   Charman, S ^a   Schofield, P M ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART INFARCTION; HEART VENTRICLE SEPTUM RUPTURE; HUMAN; MALE; MORTALITY; PROGNOSIS; RISK FACTOR; SURVIVAL;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VENTRICULAR SEPTAL RUPTURE;

EID: 0036320641     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.78.921.408     Document Type: Article

References (37)

1. ISIS-3: A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction
2. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
3. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
4. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
5. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial
6. Mechanisms of early death despite thrombolytic therapy: Experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study
7. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction
8. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction
9. Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysis
10. Frequency of left ventricular free wall rupture complicating acute myocardial infarction since the advent of thrombolysis
11. Ventricular septal rupture: A review of clinical and physiologic features and an analysis of survival
12. Myocardial rupture after acute myocardial infarction. Ten year review
13. Postinfarction ventricular septal rupture: The importance of location of infarction and right ventricular function in determining survival
14. Rupture of the interventricular septum complicating acute myocardial infarction: A multicenter analysis of clinical findings and outcome
15. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: Observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 study
16. Cardiac rupture associated with thrombolytic therapy: Impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) study
17. Ventricular septal rupture after a myocardial infarction: Clinical features and long term survival
18. Quantitative analysis of right and left ventricular infarction in the presence of postinfarction ventricular septal defect
19. Ventricular septal rupture complicating acute myocardial infarction: Identification of simple and complex types in 53 autopsied hearts
20. Clinical and pathologic features of postinfarction cardiac rupture
21. Ventricular septal and free wall rupture complicating acute myocardial infarction: Experience in the Multicenter Investigation of Limitation of Infarct Size
22. Cardiac rupture in patients with acute myocardial infarction
23. Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion
24. Myocardial rupture after myocardial infarction is related to the perfusion status of the infarct-related coronary artery
25. Patterns of coronary artery disease in post-infarction ventricular septal rupture
26. Myocardial infarct extension during reperfusion after coronary artery occlusion: Pathologic evidence
27. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow
28. Neutrophil accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion
29. Thrombolytic therapy with streptokinase stimulates collagen breakdown
30. Role of collagen in acute myocardial infarct expansion
31. The pathology of acute myocardial infarction: Definition, location, pathogenesis, effects of reperfusion, complications, and sequelae
32. A clinicopathologic study of patients with hemorrhagic myocardial infarction treated with selective coronary thrombolysis with urokinase
33. Comparison of coronary and myocardial morphologic findings in patients with and without thrombolytic therapy during fatal first acute myocardial infarction
34. Transmural, haemorrhagic myocardial infarction after intracoronary streptokinase. Clinical, angiographic, and necropsy findings
35. Urgent surgical repair of postinfarction ventricular septal rupture: Early and late outcome